查找临床试验
已按「皮肌炎」检索，对应国际通用词 dermatomyositis
共找到 15 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:25，每 5 分钟自动同步A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
United States、Argentina、Bulgaria、China、Hungary 等 12 国
年龄 18 Years – 不限
Pfizer
Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
China
年龄 5 Years – 17 Years
Chongqing Precision Biotech Co., Ltd
Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial
China
年龄 18 Years – 75 Years
Li Shiyue
Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
China
年龄 5 Years – 不限
Chongqing Precision Biotech Co., Ltd
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
United States、Australia、Austria、Bulgaria、Canada 等 12 国
年龄 18 Years – 85 Years
Chugai Pharmaceutical
Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation
China
年龄 18 Years – 80 Years
Peking Union Medical College Hospital
Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease
China
年龄 18 Years – 100 Years
Chinese PLA General Hospital
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
United States、Argentina、Bulgaria、China、France 等 12 国
年龄 18 Years – 不限
Pfizer
Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
China
年龄 5 Years – 不限
Chongqing Precision Biotech Co., Ltd
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
China
年龄 18 Years – 70 Years
The First Affiliated Hospital with Nanjing Medical University
BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy
China
年龄 18 Years – 60 Years
iCell Gene Therapeutics
RCT of Tocilizumab for Anti-MDA5+DM
China
年龄 18 Years – 65 Years
Peking Union Medical College Hospital